| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0008 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |